Share on StockTwits

Oxford Immunotec Global PLC (NASDAQ:OXFD)’s share price fell 10.9% during trading on Tuesday after the company announced weaker than expected quarterly earnings, AnalystRatings.NET reports. The company traded as low as $15.00 and last traded at $15.10, with a volume of 90,221 shares traded. The stock had previously closed at $16.95.

The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.16. The company had revenue of $11.80 million for the quarter, compared to the consensus estimate of $11.39 million. The company’s revenue for the quarter was up 15.7% on a year-over-year basis.

The stock’s 50-day moving average is $16.94 and its 200-day moving average is $19.29. The company’s market cap is $267.3 million.

Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company. The Company’s T-SPOT technology platform allows the Company to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.